Broadcom Inc. (NASDAQ:AVGO) stock is down roughly 20% from its all-time highs in June, a pullback driven by a mix of lofty AI expectations, a high valuation multiple, broader market pressures, the Mediatek-driven narrative, and more recently, Marvell Technology Inc. (NASDAQ:MRVL). Despite the drop, TD Cowen ***** yst Joshua Buchalter recently reiterated a Buy rating on the stock with a $500.00 price target.
TD Cowen remains confident in Broadcom's trajectory ahead of the print, and the numbers justify the optimism. Q2 2026 saw semiconductor revenue from AI of $10.8 billion growing 143% year-over-year, above the company's forecast, backed by increasing demand for custom AI accelerators and AI networking.
The company forecasts semiconductor revenue from AI to grow over 200 percent year-over-year to $16.0 billion. Its massive $30 billion in AI semiconductor bookings is also a reflection of the intense demand for their AI solutions.
Management has reiterated its line of sight to more than $100 billion of fiscal 2027 AI semiconductor revenue, a figure that could see material upside if the roughly 10GW opportunity is deployed. This implies that even the $100b could prove conservative.
The firm is also particularly confident about the trajectory of TPU, backed by Google's capital expenditure commentary. Back in April, the company signed a long-term agreement with Google to develop and ‌supply future generations of custom artificial intelligence chips and components for its next-generation AI racks through 2031.

#billion #year #cowen #recently

Circle Internet Group (CRCL) shares opened in the red on Aug. 3 as Wall Street ***** ysts issued conflicting calls on the NYSE-listed stablecoin company behind USDC. TD Cowen ***** ysts initiated coverage with a "Buy" rating today, but Morgan Stanley recommended against betting on a swift recovery in CRCL in the back half of 2026.
Circle stock has been in a sharp downtrend in recent months, currently down more than 50% versus its May high.
General Motors vs. Ford: 1 Auto Giant Is Winning the EV Race
1 ***** anese Company Just Waved a Red Flag for Micron Stock. How to Play It Here.
Billionaire Ken Griffin Just Saved Situational Awareness, But Here's What a Rescue Call From Citadel Really Sounds Like — 'I… Heard the Grim Reaper's Scythe'

#circle #analysts

Florida State University's men's basketball team isn't quite the nationally recognized powerhouse that the school's football program is, but it has had success in its own right. It has reached the NCAA Tournament 18 times, and while it has never officially won the national championship, it was declared the men's NCAA champions in 2020 by Florida Governor Ron DeSantis and the Florida State Legislature when the tournament was canceled that year due to the COVID-19 pandemic.
A total of 53 members of the Seminoles have been drafted into the NBA, including Scottie Barnes of the Toronto Raptors, Terance Mann of the Brooklyn Nets and the San Antonio Spurs' Devin Vassell. It is the college team Dave Cowens, the Hall of Fame center, once played for before helping the Boston Celtics win two world championships in the mid-1970s.
The Los Angeles Lakers have taken two Florida State University products in the NBA draft. Here is a look at each of them.
Jackson played a nondescript four seasons with the Seminoles before the Lakers took him in the fourth round of the 1980 draft. He played one season in the NBA with the Lakers, and in two games, he totaled two points, two rebounds, two ****** ists and two steals.
Rolle transferred to Florida State University after spending two years at Oral Roberts University, and he averaged 15.6 points and 8.5 rebounds a game with the Seminoles. He was a second-round draft pick in 1981, and while he never played in the NBA, he had a lengthy 13-year basketball career in Europe, mostly in Italy.

#tournament #Basketball

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Marriott International, Inc. will release its second-quarter earnings report before the opening bell on Monday, Aug. 3.
Analysts expect the company to report quarterly earnings of $3.08 per share, up from $2.65 per share in the year-ago period. The consensus estimate for Marriott's quarterly revenue is $7.19 billion. It reported $6.74 billion last year, according to Benzinga Pro.
Barclays ******* yst Brandt Montour, on July 21, maintained Marriott International with an Equal-Weight rating and raised the price target from $376 to $379, while TD Cowen ******* yst Kevin Kopelman maintained the stock with a Buy and increased the price target from $410 to $420.
Don't Miss:

#revenue

Updated July 27, 2026 12:23 pm ET
Listen
(4 min)
The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
0919 ET – Lundin Mining’s Caserones operations guidance could be at risk after the company found damaged powerline towers that need repairing following a storm. TD Cowen’s Craig Hutchison figures that the two-to-three weeks downtime on top of the nine days since a power outage on July 18 will hit production by 8,000 to 10,500 tons of copper. Hutchison now estimates that operations will reduce to 125,000 to 127,000 tons of copper in the year, bringing total annual production to 312,000-314,000 tons from all its operations, in line with guidance of 310,000-335,000 tons. (adriano.marchesewsj.com)

#july #updated

FedEx is introducing, but not widely advertising, a series of new charges and fees over the next two weeks that could catch customers by surprise, building on a recent pricing strategy aimed at boosting revenue without touching base rates that shippers tend to focus on.
Over an 18-month span, FedEx (NASDAQ: FDX) has implemented or announced more than 50 pricing changes, according to parcel spend management firm LJM. On top of three general rate increases have been fuel surcharge adjustments, five changes to One Rate (a flat-rate, upfront shipping program designed to provide simplicity and predictability), delivery area surcharge updates, customs-related fees, dimensional pricing changes, peak surcharges and demand surcharges.
The surcharges are typically less visible to freight owners than base rates and can have a large impact on transportation budgets.
Shippers have experienced a significant increase in fuel surcharges from FedEx, UPS and even the U.S. Postal Service as the Iran war limited crude oil supplies, pushing up the cost of diesel and jet fuel used to power their fleets, as the TD Cowen/AFS Logistics Freight Index quantified last week. Fuel surcharges in the second quarter were two-thirds higher than the prior year. Overall, the express parcel rate per package increased 5.9% in the second quarter, while the ground parcel rate per package grew 5.2%.
"The biggest takeaway is not just that FedEx is raising rates on a continual basis, but how those increases have been distributed. Many shippers now see accessorial charges in the high-30% to low-40% range as a share of spend, with some exceeding 50%, LJM said in an article on its website. The constant micro-adjustments mean businesses should review their contracts more than once a year, it added.

#shippers

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 10 affordable biotech stocks to buy right now.
On June 26, TD Cowen initiated its coverage of Dyne Therapeutics Inc. (NASDAQ:DYN), ******* igning a Buy rating to the stock. The firm stated that the company's Force platform has the potential to improve drug delivery in neuromuscular and CNS diseases by overcoming the related limitations.
Pressmaster/Shutterstock.com
Further, TD Cowen stressed the fact that the company's late-stage candidates offer the potential to become top-notch therapies. These include z-basivarsen, which targets myotonic dystrophy type 1, and z-rostudirsen, which is used for exon 51 ******* nne muscular dystrophy mutations.
On June 17, Dyne Therapeutics Inc. (NASDAQ:DYN) finalized amendments to its non-dilutive senior secured term loan arrangement with Hercules Capital. As part of the revised arrangement, $50 million had already been funded at the closing of this amendment. In addition to that, Dyne has the option to draw $50 million in term loan tranche, depending on some milestones that need to be achieved.

Alaska Air Group, Inc. (NYSE:ALK) is one of the 8 Most Undervalued Growth Stocks to Buy for the Next 10 Years. Alaska Air Group, Inc. (NYSE:ALK) has been enjoying bullish ***** yst sentiment since the start of July. So far this month, 5 ***** ysts have raised their price targets on the stock. In the latest update, Christopher Stathoulopoulos from Susquehanna raised the firm's price target on ALK from $50 to $70 and reaffirmed a Buy rating. The price target revision was based on the firm's expectations that airlines will benefit from lower fuel prices, strong travel demand, and stable ticket fares heading into the second-quarter earnings season.
In addition to Susquehanna, TD Cowen also raised its price target on Alaska Air Group, Inc. (NYSE:ALK) from $51 to $59 while maintaining its Buy rating on July 2. The firm updated its price targets across the airline sector as part of its second-quarter earnings preview.
TD Cowen said that it remains broadly positive on the airline sector, ***** uming the industry can maintain this year's ticket price increases. However, the firm said that investors will likely look for confirmation that fare increases after Labour Day remain in place. They also want to see that travel demand stays strong before the airline stocks move higher.
Alaska Air Group, Inc. (NYSE:ALK) is an airline holding company operating through the Hawaiian Airlines, Alaska Airlines, and Regional segments. The company offers scheduled passenger and cargo flights using Boeing aircraft. It also provides air transportation services through Horizon Air and other third-party carriers.
While we acknowledge the potential of ALK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

We recently published Bill Miller Portfolio: Top 10 Stock Picks. Financial Holdings, Inc. (NYSE:BFH) is one of the top stock picks.
Bread Financial Holdings, Inc. (NYSE:BFH) is a financial services company that provides credit card, loan servicing, and other ****** ociated services. Its shares are up by 54% over the past year and by 28% year-to-date. Barclays and TD Cowen discussed the firm in July. Barclays ****** ped the share price target to $104 from $70 and the rating to Equalweight from Underweight. TD Cowen also hiked Bread Financial Holdings, Inc. (NYSE:BFH)'s share price target. It raised the price target to $103 from $95 and kept a Hold rating on the stock.
With the year's first half over, Bread Financial Holdings, Inc. (NYSE:BFH) is gearing up to report its fiscal second quarter earnings. The firm has scheduled its earnings release for July 23rd. Miller Value Partners has disclosed the firm's shares in its 13F holdings since 2023. According to Insider Monkey's data, the firm first disclosed 25,725 shares that were worth $807,508 in Q2 2023. The stake peaked to being worth $18.7 million in Q2 2025.
While we acknowledge the potential of BFH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Updated July 10, 2026 4:55 pm ET
Listen
(3 min)
The latest Market Talks covering Technology, Media and Telecom. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1503 ET – Prediction markets are taking the online gaming industry by storm, with the World Cup providing the latest evidence that the category may ultimately grow larger than many investors expect, TD Cowen ****** ysts say in a note. The ****** ysts point to an acceleration in app downloads for Kalshi and Polymarket during the opening weeks of the tournament. Those trends are a sign that the category is attracting more interest, which should benefit DraftKings, whose experience with customer acquisition, product innovation and customer attention may ultimately outweigh the early traction of other prediction market platforms, they say. “While current engagement is concentrated among early movers, we view that as evidence of category formation rather than evidence that long-term winners have already been determined,” they say. (kelly.cloonanwsj.com)

BILL Holdings, Inc. (NYSE:BILL) is one of the 10 Best Stocks to Buy in Glen Kacher's Light Street Portfolio.
On June 22, 2026, TD Cowen initiated coverage of BILL Holdings, Inc. (NYSE:BILL) with a Buy rating. The firm has set a price target of $43 on the stock. According to TD Cowen's research note, the firm views the company as a leading vendor of accounting management solutions, including accounts payable, accounts receivable, and expense management for small businesses. Pointing out that improving fundamentals and execution warrant multiple expansion, the firm expects a steadier upward momentum for the shares. TD Cowen believes these positive factors will overcome muted investor sentiment following a 40% year-to-date decline.
In contrast, earlier this month, on June 10, 2026, Truist downgraded the rating on BILL Holdings, Inc. (NYSE:BILL) from Buy to Hold. The firm held a price target of $35 on the stock, down from $45. Truist believes that an acquisition of BILL Holdings, Inc. (NYSE:BILL) is increasingly unlikely due to AI-driven uncertainty. The ***** yst notes its positive catalyst path is less clear, with core revenue growth likely to decline to low-teens next year during intensifying competition.
Founded in 2006, BILL Holdings, Inc. (NYSE:BILL) is a leading provider of cloud-based software that automates financial operations for small and midsize businesses (SMEs). Headquartered in California, the company's platform streamlines accounts payable, accounts receivable, and spend management.
While we acknowledge the potential of BILL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Chewy Inc. (NYSE:CHWY) is one of the top mid-cap stocks to own for decades, according to hedge funds. On June 30, BofA Securities reiterated a Buy rating on Chewy Inc. (NYSE:CHWY) and a $31 price target. Earlier on June 23, TD Cowen touted Chewy as the best mid cap idea for 2026 while reiterating a Buy rating and a $34 price target. The price target represent significant upside potential as the stock is trading at about $20 a share.
The bullish stance comes on the heels of the company delivering solid first-quarter 2026 results, characterized by revenue and earnings growth, on June 10. The company continued to outperform the pet category while expanding profitability and free cash flow in the first quarter.
Net sales in the quarter were up 7.7% year over year to $3.36 billion, affirming strength in execution. Adjusted net income was up by $31 million to $179.9 million as adjusted diluted earnings per share increased by $0.08 to $0.43 a share.
Chewy Inc. achieved record profitability in the first quarter on the back of 200,000 net customer additions. According to Sumit Singh, Chief Executive Officer, the company is well positioned to gain market share and deliver profitable growth throughout the year. The focus is also on creating long term shareholder value.
Chewy Inc. (NYSE:CHWY) operates as a major e-commerce retailer that sells pet food, supplies, and healthcare products, primarily in the United States. The company combines the personalized service of a local pet store with the convenience of fast home delivery.

Chewy, Inc. (NYSE:CHWY) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 23, TD Cowen ***** yst William Kerr named Chewy, Inc. (NYSE:CHWY) as the firm's best small- and mid-cap, or Smid-cap, stock idea for 2026, and at the same time reiterated a Buy rating and a $34 price target on the shares.
Kerr said his firm's endorsement was built around several growth and margin levers it believes Chewy has not yet fully monetized. These include its veterinary care partnership through CVC and Modern Animal, an expanding advertising business, ongoing automation of its fulfillment operations, the Chewy+ membership program, and the integration of generative AI into its platform.
Kerr added that at the time of the note, Chewy was trading at just 6.3 times its enterprise value-to-EBITDA. He described this valuation as attractive given the company's expected EBITDA compound annual growth rate of 15% over the next five years. Put simply, the ***** yst believes the stock is too cheap relative to how fast the business is expected to grow.
The ***** yst also pointed out that as online shopping for pet products continues to grow as a share of total industry sales, Chewy is well positioned to pull customers away from physical competitors. The competitors include local pet stores, traditional retailers, and grocery chains.
The Smid-cap designation places Chewy in a curated list of TD Cowen's top investment picks for companies with a market capitalization generally below $10 billion. This is the firm's annual selection that signals its highest-conviction ideas in that size category.

Block Inc. (NYSE:XYZ) ranks among the best fintech stocks to buy as digital payments volume surges. On June 23, TD Cowen reiterated its Buy rating and $101 price target for Block Inc. (NYSE:XYZ). The firm's evaluation came after investor discussions with Block in Montreal and during the TD Cowen 2026 US Corporate Access Day in Toronto.
TD Cowen highlighted that Block's product velocity is increasing, and the company's structural reset is yielding real outcomes. According to the firm, AI is transforming how Block Inc. (NYSE:XYZ) operates, and Neighborhoods has the potential to serve as a crucial bridge between Square and Cash.
Furthermore, on June 17, Block Inc. (NYSE:XYZ) announced the release of Builderbot, an AI management tool that coordinates numerous AI agents throughout the company's codebase and operates within Slack to streamline software development tasks. The application performs over 200,000 operations each day and combines around 1,500 pull requests every week, accounting for roughly 15% of all production code changes throughout Block Inc. (NYSE:XYZ).
Block Inc. (NYSE:XYZ), founded in 2009 by Jack Dorsey, is an American financial services company. It offers point-of-sale systems and credit solutions to merchants through its Square subsidiary. It offers peer-to-peer payment, banking, and Bitcoin trading through its Cash App platform.
While we acknowledge the potential of XYZ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Universal Health Services, Inc. (NYSE:UHS) is one of the Top 10 Extreme Value Stocks To Buy Now. On June 22, TD Cowen lowered the firm's price target on Universal Health Services, Inc. (NYSE:UHS) from $230 to $197 and kept a Buy rating on the stock. The downward price target revision still reflects a 24% upside from current levels. After a May hospital survey showed that revenue remained largely flat compared to the previous year, the firm lowered its growth expectations for 2026 and 2027. According to the survey, weaker surgical procedure volumes were partly offset by growth in other medical services.
The healthcare industry is well positioned to benefit from the AI tailwind. By using artificial intelligence to improve efficiency, lower labor costs, and better manage complex reimbursement processes, hospitals may strengthen their competitive position and profitability over time, according to UBS. While health insurers are expected to benefit from these efficiency improvements, the firm believes hospitals could be the biggest beneficiaries.
Moreover, large hospital operators such as HCA Healthcare, Tenet Healthcare, and Universal Health Services, Inc. (NYSE:UHS) have already begun deploying AI in areas such as billing and reimbursement management, staffing, and clinical documentation. The firm believes these companies could maintain an advantage over many nonprofit hospitals for several years.
Universal Health Services, Inc. (NYSE:UHS) provides hospital and healthcare services through more its acute care hospitals, behavioral health facilities, outpatient centers, and ambulatory care access points across the US, Puerto Rico, and the UK.
While we acknowledge the potential of UHS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Lincoln National Corporation (NYSE:LNC) is one of the Top 10 Extreme Value Stocks To Buy Now. On June 24, Lincoln National Corporation (NYSE:LNC) entered into an underwriting agreement with a syndicate led by Wells Fargo Securities, BofA Securities, Goldman Sachs, Morgan Stanley, and TD Cowen Securities to issue $500 million in subordinated notes. The notes carry a fixed-to-fixed reset interest rate of $6.800% and will mature on July 15, 2056. The offering was priced at face value and completed on June 29, 2026, with the bonds sold at a small discount of 1% to the underwriting group. The notes are unsecured and rank below the company's senior debt. They carry a fixed 6.800% interest rate until July 15, 2036, after which the rate will reset every five years based on the 5-year US Treasury yield plus 2.400%. Interest payments will be made twice a year starting January 15, 2027.
Lincoln National Corporation (NYSE:LNC) plans to use the proceeds for general corporate purposes, which may include redeeming higher-cost preferred stock. This move is aimed at adjusting its capital structure and potentially reducing long-term financing costs over time. On a positive front, on June 15, a Jefferies ****** yst reiterated a Buy rating on Lincoln National Corporation (NYSE:LNC) along with the target price of $56. This price target matches the highest Wall Street price target among 16 ****** ysts covering the stock.
Lincoln National Corporation (NYSE:LNC), through its subsidiaries, provides insurance and retirement policies. The company is based in Radnor, Pennsylvania and was founded in 1968.
While we acknowledge the potential of LNC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Iran Peace Deal Sends Oil Lower: Top 8 Travel Stocks to Buy Now and 8 Hidden Multibagger Stocks to Buy Now.

T-Mobile US, Inc. (NASDAQ:TMUS) has declined roughly 10% over the past 30 days, mainly due to competitive pressure from ***** eX's Starlink push in mobile services. However, ***** ysts project roughly 42% upside from the current level, driven by the company's aggressive 5G monetization. T-Mobile US, Inc. (NASDAQ:TMUS) ranks as one of the Top Large Cap Stocks to Invest In At 52-Week Lows.
Recently, on June 26, Reuters reported that ***** eX has told investors it is planning to launch a direct retail mobile service for US consumers under the Starlink brand. This will place the company in direct competition with T-Mobile, Verizon, and AT&T.
The report noted that ***** eX President Gwynne Shotwell, during the IPO roadshow, reportedly disclosed that the company is considering building its own terrestrial US mobile network. This goes well beyond the company's current partnership with T-Mobile, which only provides supplemental satellite coverage in remote areas. Moreover, the move is supported by significant spectrum acquisitions. The company purchased wireless spectrum licenses from EchoStar in two deals totaling around $17 billion, giving it the airwaves needed to offer a robust and affordable direct-to-cell service.
Recently, TD Cowen ***** yst Gregory Williams floated the idea that ***** eX could eventually look to acquire T-Mobile as part of its ambition to build a full-scale wireless and broadband platform. He noted that Starlink is no longer just a satellite internet service and aims to become a comprehensive connectivity network spanning broadband, mobile, and a hybrid of satellite and ground-based wireless infrastructure. To achieve that, ***** eX would likely need a wholesale network agreement with a major US carrier such as T-Mobile.
T-Mobile US Inc. (NASDAQ:TMUS) is a telecom services company that offers wireless communications services, such as voice, messaging, and data, to postpaid, prepaid, and wholesale customers. The company also deals in wireless devices.

HCA Healthcare, Inc. (NYSE:HCA) is one of the best non-tech stocks to buy according to ***** ysts. TD Cowen cut the price target on HCA Healthcare, Inc. (NYSE:HCA) to $431 from $500 on June 22 and maintained a Buy rating on the shares. The firm told investors in a research note that it reduced the company's 2026 and 2027 growth ***** umptions after its May hospital survey showed flat year-over-year revenue. It further stated that the survey commentary shows weaker surgical volumes that were partially offset by growth in medical volumes.
In a separate development, HCA Healthcare, Inc. (NYSE:HCA) and The College of Health Care Professions announced on May 27 an agreement for HCA Healthcare to acquire ownership of CHCP. CHCP provides healthcare education to more than 8,000 students per year, across 10 campuses throughout Texas and online. Management stated that the agreement highlights a shared commitment to academic quality, student success, and workforce readiness. HCA Healthcare and CHCP have been partnering for decades, primarily through clinical sites, program advisory boards, and career placement.
HCA Healthcare, Inc. (NYSE:HCA) is a health services company involved in operating hospitals, urgent care facilities, freestanding surgery centers, emergency care facilities, walk-in clinics, diagnostic and imaging centers, comprehensive rehabilitation and physical therapy centers, radiation and oncology therapy centers, and several more. The company operates general and acute care hospitals that offer medical and surgical services.
While we acknowledge the potential of HCA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

X-Energy, Inc. (NASDAQ:XE) is one of the 10 Best New Stocks to Buy Other Than ******* eX.
On June 23, 2026, TD Cowen named X-Energy, Inc. (NASDAQ:XE) a best smid-cap idea for 2026 and kept a Buy rating with a $35 price target. TD Cowen said the stock's pullback after the Q1 report looked overdone. The firm also said the Amazon power agreement submittal shift should not affect the project timeline and sees several catalysts that could help de-risk the X-energy story later this year.
On June 4, X-energy reported Q1 revenue of $43.4M, versus the $67.87M consensus. CEO J. Clay Sell said the company's first earnings announcement as a public company marked an "important moment," pointing to progress in commercializing advanced nuclear technology at scale. Sell said X-energy remained focused on advancing the Xe-100 and TRISO-X fuel while strengthening its regulatory and commercial foundation. CFO Daniel Gross said the recent IPO improved X-energy's liquidity profile, providing approximately $1.1B in net proceeds of additional capital.
Earlier in June, X-Energy submitted an application to enter the United Kingdom's Generic Design ******* sment process for its Xe-100 High Temperature Gas-cooled Reactor. Subject to acceptance, the submission marks a significant milestone in X-energy and Centrica's efforts to deploy up to 6 GW of new nuclear in the United Kingdom.
X-Energy, Inc. (NASDAQ:XE) designs and develops nuclear reactor technology.

Intercontinental Exchange Inc. (NYSE:ICE) is one of the best non-tech stocks to buy according to ******* ysts. TD Cowen cut the price target on Intercontinental Exchange Inc. (NYSE:ICE) to $153 from $193 on June 22 and maintained a Buy rating on the shares. The firm told investors in a research note that it cut price targets for the majority of its exchange coverage. It added that the emergence of perpetual futures is likely to keep alive "terminal value" concerns and curb stock multiples even as volumes are generally trending favorably.
Intercontinental Exchange Inc. (NYSE:ICE) reported its May 2026 statistics on June 3, stating that the total average daily volume (ADV) rose 14% year-over-year, with open interest (OI) up 24% year-over-year, including a record OI of 130.6M lots on May 25. Total Energy OI rose 6% year-over-year, including record options OI of 31.2M lots on May 22. The company also reported that the total Agriculture & Metals ADV grew 60% year-over-year, with OI up 39% year-over-year.
Intercontinental Exchange Inc. (NYSE:ICE) is involved in the provision of market infrastructure, data services, and technology solutions. The company's operations are divided into the following segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology.
While we acknowledge the potential of ICE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

With an annual dividend yield of 2.31%, CME Group Inc. (NASDAQ:CME) is included among the 12 Best NASDAQ Stocks to Buy for Dividends.
CME Group Inc. (NASDAQ:CME) is the world's leading and most diverse derivatives marketplace offering the widest range of futures and options products for risk management.
On June 22, TD Cowen lowered its price target on CME Group Inc. (NASDAQ:CME) from $332 to $273, but maintained a 'Buy' rating on the shares. Despite the cut, the revised price objective reflects an upside of over 21% from the current levels.
TD Cowen reduced its price targets across most of its exchange coverage. According to the **** yst firm, the growing popularity of perpetual futures is likely to sustain concerns about "terminal value" and limit stock multiples, even as trading volumes continue to trend positively.
On the other hand, Keefe Bruyette upgraded CME Group Inc. (NASDAQ:CME) from 'Market Perform' to 'Outperform' on June 18, while keeping its price target on the stock unchanged at $305.

Microsoft Corporation (NASDAQ:MSFT) ranks as the Best Data Center Stocks That Are Cheaper Than the S&P 500. Although the stock has declined roughly 21% on a year-to-date basis over macroeconomic concerns and massive AI capital expenditure forecasts, the Street expects more than 44% upside over the next 12 months.
Recently, on June 15, Reuters reported that Microsoft Corporation (NASDAQ:MSFT) is facing a lawsuit from the shareholders accusing the company of securities fraud, with plaintiffs claiming it concealed slowing growth in its Azure cloud business and downplayed the cost of its AI infrastructure buildout.
According to Reuters, the case was filed in Seattle federal court and was followed by a 10% single-day drop in Microsoft's stock on January 29, which wiped out roughly $357 billion in market value. The trigger for the lawsuit was the company's fiscal second-quarter earnings, which showed Azure revenue growth slipping to 39% from 40% the prior quarter, with a further projected slowdown to 37%–38%. Moreover, the capital spending also came in at $37.5 billion, up 66% year-over-year and above **** yst expectations.
The lawsuit alleges Microsoft failed to adequately disclose that AI-related investments, including its Copilot chatbot and OpenAI partnership, were straining resources and constraining Azure's growth capacity. Microsoft has called the claims "without merit" and says it will vigorously defend itself.
That said, TD Cowen maintained a Buy rating on Microsoft Corporation (NASDAQ:MSFT) with a $540 price target on June 4. The firm highlighted that the company has launched seven new self-built AI models designed for fine-tuning and cost optimization. TD Cowen sees this as a meaningful shift in how Microsoft approaches AI development. The firm also noted that these models will reduce the company's dependency on external frontier labs for AI capabilities.

DexCom, Inc. (NASDAQ:DXCM) is one of the 12 High Quality Stocks to Buy for the Long Term.
On June 15, 2026, Piper Sandler **** yst Matt O'Brien raised the firm's price target on DexCom, Inc. (NASDAQ:DXCM) to $88 from $75 and maintained an Overweight rating on the shares. O'Brien said Piper Sandler updated some of its models to better align with quarterly cadence, company guidance, and consensus estimates. For DexCom, the firm cited greater visibility into the long-term pipeline and catalyst cadence supporting sustained, outsized top-line growth.
On June 12, 2026, the U.S. Food and Drug Administration cleared DexCom, Inc.'s (NASDAQ:DXCM) Stelo Glucose Biosensor System for marketing as the first over-the-counter continuous glucose monitor for children. The integrated CGM is indicated for people two years of age and older who do not use insulin. The FDA had previously cleared Stelo OTC for individuals 18 years and older in March 2024. Michelle Tarver, Director of the Center for Devices and Radiological Health, said the clearance reflects the FDA's commitment to supporting innovation for pediatric patients.
Pixabay/Public Domain
On June 10, 2026, TD Cowen **** yst Joshua Jennings raised the firm's price target on DexCom, Inc. (NASDAQ:DXCM) to $95 from $75 and maintained a Buy rating on the shares. Jennings said DexCom appears to be at the forefront of the T2NIT coverage expansion initiative and that CONNECT represents a compelling dataset for payers. TD Cowen views DexCom as a share gainer in the U.S. T2NIT market, while noting that incremental access should benefit all players because of the size of the opportunity.

DexCom, Inc. (NASDAQ:DXCM) is one of the 12 High Quality Stocks to Buy for the Long Term.
On June 15, 2026, Piper Sandler **** yst Matt O'Brien raised the firm's price target on DexCom, Inc. (NASDAQ:DXCM) to $88 from $75 and maintained an Overweight rating on the shares. O'Brien said Piper Sandler updated some of its models to better align with quarterly cadence, company guidance, and consensus estimates. For DexCom, the firm cited greater visibility into the long-term pipeline and catalyst cadence supporting sustained, outsized top-line growth.
On June 12, 2026, the U.S. Food and Drug Administration cleared DexCom, Inc.'s (NASDAQ:DXCM) Stelo Glucose Biosensor System for marketing as the first over-the-counter continuous glucose monitor for children. The integrated CGM is indicated for people two years of age and older who do not use insulin. The FDA had previously cleared Stelo OTC for individuals 18 years and older in March 2024. Michelle Tarver, Director of the Center for Devices and Radiological Health, said the clearance reflects the FDA's commitment to supporting innovation for pediatric patients.
Pixabay/Public Domain
On June 10, 2026, TD Cowen **** yst Joshua Jennings raised the firm's price target on DexCom, Inc. (NASDAQ:DXCM) to $95 from $75 and maintained a Buy rating on the shares. Jennings said DexCom appears to be at the forefront of the T2NIT coverage expansion initiative and that CONNECT represents a compelling dataset for payers. TD Cowen views DexCom as a share gainer in the U.S. T2NIT market, while noting that incremental access should benefit all players because of the size of the opportunity.

Recent ****** yst ratings make Global Payments Inc. (NYSE:GPN) one of the 10 best payment processing stocks to buy now. On June 11, Bryan Bergin from TD Cowen decreased the price target from $86 to $74 on Global Payments Inc. (NYSE:GPN), resulting in a revised upside potential of almost 19%. The ****** yst reiterated his Hold rating on the stock.
Bergin mentioned that TD Cowen has revised its model to reflect a more cautious outlook with regard to previously disclosed headwinds, which now appear more likely to occur. He pointed out that despite this cautious short-term adjustment, the company's projections about an expected increase in the second half of 2026 have not changed.
Robert Kneschke/Shutterstock.com
Earlier, on June 3, Susquehanna also reaffirmed its Positive rating on Global Payments Inc. (NYSE:GPN). The firm reduced the price target from $119 to $111, which translates into a revised upside potential of more than 77%.
After a closer look at public transcripts and travel-related ****** umptions, the firm changed its estimates. Susquehanna toned down its projections by reducing its growth ****** umptions to 3.2% for the second quarter, 5% for the second half, and 4% for the entire year 2026.

Recent **** yst ratings make Global Payments Inc. (NYSE:GPN) one of the 10 best payment processing stocks to buy now. On June 11, Bryan Bergin from TD Cowen decreased the price target from $86 to $74 on Global Payments Inc. (NYSE:GPN), resulting in a revised upside potential of almost 19%. The **** yst reiterated his Hold rating on the stock.
Bergin mentioned that TD Cowen has revised its model to reflect a more cautious outlook with regard to previously disclosed headwinds, which now appear more likely to occur. He pointed out that despite this cautious short-term adjustment, the company's projections about an expected increase in the second half of 2026 have not changed.
Robert Kneschke/Shutterstock.com
Earlier, on June 3, Susquehanna also reaffirmed its Positive rating on Global Payments Inc. (NYSE:GPN). The firm reduced the price target from $119 to $111, which translates into a revised upside potential of more than 77%.
After a closer look at public transcripts and travel-related **** umptions, the firm changed its estimates. Susquehanna toned down its projections by reducing its growth **** umptions to 3.2% for the second quarter, 5% for the second half, and 4% for the entire year 2026.